India News | WHO's Supply Suspension of Covaxin Not to Impact Travel of People: MEA

New Delhi, Apr 7 (PTI) Days after the WHO suspended the supply of Covaxin through UN procurement agencies, India on Thursday said the move would not impact travel by people who have taken the vaccine.

External Affairs Ministry Spokesperson Arindam Bagchi said the efficacy of the vaccine is not in question and that the decision by the World Health Organization (WHO) should not be a cause for worry at all.

Also Read | Delhi Shocker: 5-Year-Old Dies in Accident in Dwarka, Family Alleges Murder in Road Rage.

"I certainly do not think there should be any impact at all on people who have taken Covaxin. It is a safe vaccine. In terms of their travel, it continues to be recognised under the EUL (emergency use authorisation) of WHO," he said.

Bagchi was replying to questions on the WHO's decision.

Also Read | 'Hindi Should Be an Alternative Language to English', Says Home Minister Amit Shah.

"Various countries have already accepted it. We have also had mutual recognition of vaccination certificate arrangements with various countries," Bagchi said.

He said the issue was something to do with certain processes and manufacturer of Covaxin and the WHO are looking into the matter.

Bagchi said his understanding was that the efficacy of the vaccine was not in question and there is something about process issues that are being worked out by the company and the WHO.

A statement issued by WHO on Saturday said the suspension is in response to the outcomes of its post-EUL (emergency use authorisation) inspection and the need to conduct process and facility upgrades to address recently identified GMP (good manufacturing practice) deficiencies.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)